The NF-B signaling cascade relays external signals essential for B-cell growth and survival. 
between these zones result in the generation of high-affinity, often isotype-switched memory B cells and plasma cells (PCs) (2) (3) (4) (5) . The GC reaction is critical for immunity; however, errors during SHM and class-switch recombination can lead to genetic aberrations that promote lymphomagenesis (6, 7) . Recently, genetic mutations resulting in constitutive activation of the NF-B signaling cascade were identified in a large fraction of GC-derived B-cell lymphomas and multiple myeloma (MM) (8) (9) (10) (11) (12) (13) (14) (15) (16) ).
Activation of NF-B signaling results in the transcription of NF-B target genes that regulate many cellular processes including cell survival and proliferation (17, 18) . The NF-B-signaling cascade comprises two branches, the canonical and alternative (or noncanonical) NF-B pathways, which activate specific NF-B transcription factor subunits that occur mainly as heterodimers. Canonical NF-B pathway activation leads to the nuclear translocation of c-REL, RELA and p50, while alternative pathway activation causes nuclear translocation of RELB and p52. In normal cells, NF-B activation is transient and tightly controlled. Conversely, constitutive NF-B activation due to genetic alterations in NF-B pathway components is pathogenic (8, 9) .
Mutations affecting multiple different NF-B signaling components have been identified in several GC-derived B-cell malignancies which can lead to the constitutive activation of the canonical and/or alternative NF-B pathways (8) (9) (10) (11) (12) (13) (14) (15) (16) . The selection of these mutations implies that NF-B-signaling may have an important biological role during normal GC B-cell development that is "hijacked" in tumors (7, 8) .
Distinguishing the functions of the canonical and alternative NF-B pathways by studying upstream regulators may be complicated by the possibility of pathway crosstalk.
Therefore, focusing on the downstream transcription factor subunits may help to clarify the specific roles of the separate NF-B pathways. Towards this aim, early work on human lymphoid tissue revealed that nuclear translocation of canonical NF-B subunits within GCs occurred only within a subset of cells in the LZ (19) . By ablating the canonical NF-B transcription factors c-REL or RELA specifically in GC B cells, we recently showed that c-REL was essential for GC maintenance, whereas RELA was required for PC development (20) . The expression, activation status and function of the alternative NF-B transcription factors RELB and p52 in GC B cells remain largely unknown. Due to the diverse functions of the alternative NF-B pathway in a range of cell types, mice with constitutional knockout of either relb or nfkb2
(the gene encoding the p100/p52 precursor, referred to as NF-B2, from which p52 is generated upon activation) have severe defects in lymphoid organization (21) (22) (23) , thus hampering the analysis of GC B-cell development in these mice. We here determined the expression pattern of the alternative NF-B subunits in human lymphoid tissue and investigated their roles during GC B-cell development in vivo by crossing conditional relb and/or nfkb2 alleles to mice that express
Cre-recombinase in GC B-cells. We found that RELB and NF-B2 were jointly required to maintain the GC B-cell reaction while the development of antigen-specific PCs was impaired upon deletion of only nfkb2 in GC B-cells. Interestingly, we observed strong staining of p100/p52 in PCs localizing in the tonsillar subepithelium that were identified by staining for the major PC regulator BLIMP1 (26, 27) , relative to lymphocytes at the border of the subepithelium (Fig. 1C, top) . The same staining pattern was observed in BLIMP1 + PC precursors in the LZ of tonsillar GCs (Fig. 1C, bottom ).
RESULTS

Expression
These observations may point towards a potential role of the alternative NF-B pathway in the development of normal PCs and their precursors in the GC. The large amount of NF-B2 in the cytoplasm may predispose BLIMP1 + plasma cell precursors and plasma cells to undergo strong signaling via the alternative NF-B pathway upon stimulation. Alternative pathway activation was observed via strong p100 p52 processing in two MM cell lines (Fig. 1D ), and to a lesser extent in a cell line corresponding to diffuse large B-cell lymphoma (DLBCL), where mutations leading to activation of the alternative pathway have been observed in a subset of cell lines and primary cases (13, 15) . Of note, Western-blot analysis revealed that the canonical NF-B subunit c-REL was expressed at dramatically lower levels in the MM lines compared to the DLBCL lines (Fig. 1D) . A low expression of c-REL relative to surrounding lymphocytes appears to also be a feature of normal PC precursors in the LZ (Fig. 1E , right), as identified by strong staining for IRF4 which at high expression levels promotes PC differentiation along with BLIMP1 (27, 28) . In contrast, cytoplasmic p100/p52 expression is increased in several IRF4 + cells (Fig.   1E , left), similar to the corresponding BLIMP1 staining (Fig. 1c, C 1-Cre and C 1-Cre control mice were observed; however, these differences were minor and do not point towards a preferential loss of a specific GC B-cell subpopulation. Thus, these data suggest that RELB and NF-B2 are required for the maintenance of both DZ and LZ subpopulations past d7 of the GC reaction. The second largest group of signatures identified in the GSEA analysis was associated with the metabolism of proteins (Fig. 3B) . In addition, when we compared our RNA-seq data set to a library of normal and pathological lymphoid gene expression signatures (34) , five signatures were found to be enriched in RELB/NF-B2-proficient vs. deficient GC B cells (SI Appendix, Fig.   S4 ), including a ribosomal protein signature and two X box-binding protein-1 (XBP1)-associated gene expression signatures. XBP-1 is required for the unfolded protein response and is essential for the development of PCs capable of secreting large amounts of antibodies (26, 27) .
This suggests that in GC B cells, the alternative NF-B subunits may be required to set up a program that allows for the efficient production of proteins and facilitates antibody secretion, presumably in GC B cells destined to become plasmablasts (see below). (Fig. 4A) , GC-specific deletion of nfkb2 led to a ~3-fold reduction in NP-specific IgG1 serum levels and an 8-10-fold reduction in ASCs compared to the control mice (Fig. 4B ). This defect does not appear to be due to the loss of plasma cells, as we were able to detect eGFP + , and therefore nfkb2-deleted, CD138 + plasma cells (see SI Appendix, Fig. S7&8 ). While the basis for this observation remains to be determined, these results provide functional evidence for a biological role of NF-B2, which is highly expressed in PCs and their precursors, in the development of PCs that cannot be complemented by other NF-B subunits.
DISCUSSION
In agreement with previous work using bone-marrow chimeras (21, 23), we found that GC B-cell development proceeds normally in mice with GC B cell-specific ablation of either RELB or NF-B2 alone. In contrast, combined ablation of RELB and NF-B2 resulted in the progressive loss of GC B cells. Therefore, RELB and NF-B2 are jointly required for the maintenance of the GC reaction.
Among the alternative NF-B subunits, only RELB is a transcriptional activator. regulator of the alternative NF-B pathway that can also activate the canonical pathway (42, 43) , are all required for the maintenance of established GCs (20, (44) (45) (46) (47) . We here demonstrated that RELB and NF-B2 have a similarly critical role in this process.
It is becoming increasingly clear that individual NF-B subunits have divergent roles in GC and post-GC development. In the case of the canonical subunits, RELA is dispensable for the GC reaction but promotes PC development, whereas c-REL is required for GC maintenance 
MATERIAL AND METHODS
Mice. The conditional relb and nfkb2 alleles, C 1-Cre and CD19-cre mice have been described (29, 30, 50) . Mice were housed and treated in compliance with the guidelines of Columbia University. The animal protocol was approved by the institution's IACUC. Mice were immunized with SRBCs or NP-KLH in complete Freund's adjuvant as described (20) .
Cell culture. Discarded leftovers from routine tonsillectomies performed on children at
Columbia-Presbyterian Medical Center were obtained. IRB approval was obtained for all procedures. Consent was not required since all patient identifiers were deidentified and specimens anonymized before use. Human GC B cells were isolated as described (51) . Human Immunoblot analysis. Cell lines or human GC B cells were subjected to immunoblot analysis as described (20) . For antibodies used, see Table S1 .
Flow cytometry. Spleen cell suspensions were stained and analyzed as described (20) . For antibodies used, see Table S1 . The CellTrace Violet Proliferation Kit (Thermo Fisher) was used for cell trace experiments. For the analysis of BrdU incorporation in GC B cells in vivo, mice were injected with 2 mg of BrdU and sacrificed 6h later. Staining for BrdU was conducted using the APC-BrdU kit (Becton Dickinson).
Histology and immunohistochemistry. Spleen-sections (4m) were H&E-stained for morphological evaluation. Immunohistochemical staining analysis was performed as described (20) . For antibodies used, see Table S1 .
Immunofluorescence. For single-cell staining, cells were spun onto slides using a cytocentrifuge and fixed in 10% formalin for 20m followed by 20m of methanol fixation. Nuclear permeabilization was achieved via incubation with 0.2% triton/PBS. Cytospin slides were incubated with primary antibodies overnight followed by incubation with a Cy3-conjugated antibody. Slides were counterstained with DAPI (Molecular Probes). Images were acquired with an Eclipse E400 microscope (Nikon). Tissue sections were prepared and stained as described (51) . For antibodies used, see Table S1 . to determine significant enrichment (FDR<25%, P≤ 0.05).
ELISA and ELISPOT.
ELISA and ELISPOT-analysis for NP-specific IgG1 or NP-specific IgG1
antibody-secreting cells, respectively, was conducted as described (20) . 
